Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 23, 1993 - Issue 12
38
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Disposition and urinary metabolic pattern of cabergoline, a potent dopaminergic agonist, in rat, monkey and man

, , , , &
Pages 1377-1389 | Received 21 May 1993, Published online: 22 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Annamaria Colao, Gaetano Lombardi & Lucio Annunziato. (2000) Cabergoline. Expert Opinion on Pharmacotherapy 1:3, pages 555-574.
Read now

Articles from other publishers (8)

Takashi Tsuboi, Hirohisa Watanabe, Masahisa Katsuno & Gen Sobue. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 3253 3262 .
Takashi Tsuboi, Hirohisa Watanabe, Masahisa Katsuno & Gen Sobue. 2019. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1 10 .
David J. Unett, Joel Gatlin, Todd L. Anthony, Daniel J. Buzard, Steve Chang, Chuan Chen, Xiaohua Chen, Huong T.-M. Dang, John Frazer, Minh K. Le, Abu J. M. Sadeque, Charles Xing & Ibragim Gaidarov. (2013) Kinetics of 5-HT 2B Receptor Signaling: Profound Agonist-Dependent Effects on Signaling Onset and Duration . Journal of Pharmacology and Experimental Therapeutics 347:3, pages 645-659.
Crossref
Alexandra Kekewska, Harald Hübner, Peter Gmeiner & Heinz H. Pertz. (2011) The Bulky N(6) Substituent of Cabergoline Is Responsible for Agonism of This Drug at 5-Hydroxytryptamine (5-HT) 2A and 5-HT 2B Receptors and Thus Is a Determinant of Valvular Heart Disease . Journal of Pharmacology and Experimental Therapeutics 338:1, pages 381-391.
Crossref
Akiko Nakatsuka, Masahiro Nagai, Hayato Yabe, Noriko Nishikawa, Takuo Nomura, Hiroyoko Moritoyo, Takashi Moritoyo & Masahiro Nomoto. (2006) Effect of Clarithromycin on the Pharmacokinetics of Cabergoline in Healthy Controls and in Patients With Parkinson’s Disease. Journal of Pharmacological Sciences 100:1, pages 59-64.
Crossref
Manuela Contin, Roberto Riva, Fiorenzo Albani & Agostino Baruzzi. (2000) Pharmacokinetic Optimisation of Dopamine Receptor Agonist Therapy for Parkinson??s Disease. CNS Drugs 14:6, pages 439-455.
Crossref
P. Angiuli, E. Fontana & P. Dostert. (1997) Synthesis of [17-14C] nicergoline. Journal of Labelled Compounds and Radiopharmaceuticals 39:4, pages 331-337.
Crossref
Richard Grondin & Paul J. Bédard. (2006) Cabergoline: A Promising Agent for the Treatment of Parkinson's Disease. CNS Drug Reviews 2:2, pages 214-225.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.